Methods For Nucleic Acid Manipulation

US2016265015A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016265015-A1
Application numberUS-201615070401-A
CountryUS
Kind codeA1
Filing dateMar 15, 2016
Priority dateApr 20, 2001
Publication dateSep 15, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method for replicating and amplifying a target nucleic acid sequence is described. A method of the invention involves the formation of a recombination intermediate without the prior denaturing of a nucleic acid duplex through the use of a recombination factor. The recombination intermediate is treated with a high fidelity polymerase to permit the replication and amplification of the target nucleic acid sequence. In preferred embodiments, the polymerase comprises a polymerase holoenzyme. In further preferred embodiments, the recombination factor is bacteriophage T4 UvsX protein or homologs from other species, and the polymerase holoenzyme comprises a polymerase enzyme, a clamp protein and a clamp loader protein, derived from viral, bacteriophage, prokaryotic, archaebacterial, or eukaryotic systems.

First claim

Opening claim text (preview).

1 .- 22 . (canceled) 23 . A method for amplifying a target DNA, said method comprising the steps: i) forming a reaction mixture comprising said target DNA, bacteriophage UvsX protein, two primers that anneal to the flanking ends of said target DNA, a DNA polymerase, and nucleotides in an amount sufficient to support amplification of said target DNA sequence; ii) maintaining the reaction mixture at a temperature below about 45° C., wherein amplified target DNA is produced; iii) and detecting the presence of amplified target DNA. 24 . The method of claim 23 , wherein said DNA polymerase is a non-thermostable polymerase. 25 . The method of claim 23 , wherein said DNA polymerase is a prokaryotic polymerase. 26 . The method of claim 23 , wherein said DNA polymerase is a polymerase holoenzyme. 27 . The method of claim 23 , wherein said reaction mixture further comprises bacteriophage UvsY protein, bacteriophage gene product 32 protein, or both. 28 . The method of claim 23 , wherein said reaction mixture further comprises a helicase. 29 . The method of claim 23 , wherein said reaction mixture further comprises an ATP regeneration system. 30 . A method for amplifying a target DNA, said method comprising the steps: i) forming a reaction mixture comprising said target DNA, bacteriophage UvsX protein, bacteriophage UvsY protein, two primers that anneal to the flanking ends of said target DNA, a DNA polymerase, and nucleotides in an amount sufficient to support amplification of said target DNA sequence; ii) maintaining the reaction mixture at a temperature below about 45° C., wherein amplified target DNA is produced; iii) and detecting the presence of amplified target DNA. 31 . The method of claim 30 , wherein said DNA polymerase is a non-thermostable polymerase. 32 . The method of claim 30 , wherein said DNA polymerase is a prokaryotic polymerase. 33 . The method of claim 30 , wherein said DNA polymerase is a polymerase holoenzyme. 34 . The method of claim 30 , wherein said reaction mixture further comprises bacteriophage gene product 32 protein. 35 . The method of claim 30 , wherein said reaction mixture further comprises a helicase. 36 . The method of claim 30 , wherein said reaction mixture further comprises an ATP regeneration system. 37 . A method for amplifying a target DNA, said method comprising the steps: i) forming a reaction mixture comprising said target DNA, bacteriophage UvsX protein, two primers that anneal to the flanking ends of said target DNA, a DNA polymerase, and nucleotides in an amount sufficient to support amplification of said target DNA sequence; ii) maintaining the reaction mixture at room temperature, wherein amplified target DNA is produced; iii) and detecting the presence of amplified target DNA. 38 . The method of claim 37 , wherein said DNA polymerase is a non-thermostable polymerase. 39 . The method of claim 37 , wherein said DNA polymerase is a prokaryotic polymerase. 40 . The method of claim 37 , wherein said DNA polymerase is a polymerase holoenzyme. 41 . The method of claim 37 , wherein said reaction mixture further comprises bacteriophage UvsY protein, bacteriophage gene product 32 protein, or both. 42 . The method of claim 37 , wherein said reaction mixture further comprises a helicase, an ATP regeneration system, or both.

Assignees

Inventors

Classifications

  • C12P19/34Primary

    Polynucleotides, e.g. nucleic acids, oligoribonucleotides · CPC title

  • by DNA shuffling, e.g. RSR, STEP, RPR · CPC title

  • Nucleic acid amplification reactions · CPC title

  • Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • Polymerase chain reaction [PCR] · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016265015A1 cover?
A method for replicating and amplifying a target nucleic acid sequence is described. A method of the invention involves the formation of a recombination intermediate without the prior denaturing of a nucleic acid duplex through the use of a recombination factor. The recombination intermediate is treated with a high fidelity polymerase to permit the replication and amplification of the target nu…
Who is the assignee on this patent?
Penn State Res Found
What technology area does this patent fall under?
Primary CPC classification C12P19/34. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Sep 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).